TAO : Treatment of Acute Coronary Syndromes with Otamixaban Philippe Gabriel Steg* on behalf of the TAO investigators *DHU-FIRE, Hôpital Bichat, Assistance.
Max Shirshov +7-967-0693828 [email protected] AlgoSec Security Management Suite.
Early Management of Atrial Fibrillation to Prevent Cardiovascular Complications Supported by an unrestricted educational grant from Sanofi.
Part VII – Non-Hodgkin Lymphoma/ Chronic Lymphocytic Leukemia Tuesday, July 26, 2011 7:30 PM – 8:30 PM ET RTP TV: An 8-Part Live CME Webcast Series.
Part I – Triple-Negative Breast Cancer: The New Biology Tuesday, June 14, 2011 7:30 PM - 8:30 PM ET RTP TV: An 8-Part Live CME Webcast Series.
Page 1 Sachs I/O Investment Forum Chicago USA © Defined Health, May 29, 2015 Sachs Immuno-Oncology: BD&L and Investment Forum Pharma-Biotech BD&L Panel.
Richard K Zimmerman MD MPH University of Pittsburgh School of Medicine.
